BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31418851)

  • 1. The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS).
    Osborne JP; Edwards SW; Dietrich Alber F; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FJK;
    Epilepsia; 2019 Sep; 60(9):1861-1869. PubMed ID: 31418851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
    Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
    Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.
    O'Callaghan FJ; Lux AL; Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; Osborne JP
    Epilepsia; 2011 Jul; 52(7):1359-64. PubMed ID: 21668442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification.
    Osborne JP; Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; O'Callaghan FJ
    Epilepsia; 2010 Oct; 51(10):2168-74. PubMed ID: 20726878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
    Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Lux AL; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Arch Dis Child; 2010 May; 95(5):382-6. PubMed ID: 20457702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latest on infantile spasms.
    Riikonen R
    Curr Opin Neurol; 2005 Apr; 18(2):91-5. PubMed ID: 15791136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
    Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
    Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
    Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
    Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG.
    Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA
    Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infantile spasms.
    Haines ST; Casto DT
    Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile Spasms and West Syndrome - A Clinician's Perspective.
    Chopra SS
    Indian J Pediatr; 2020 Dec; 87(12):1040-1046. PubMed ID: 32557136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to treatment in a prospective national infantile spasms cohort.
    Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
    Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
    Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
    Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.